{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:24:59Z","timestamp":1791091499481,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"crossref"}]},{"name":"bioMerieux"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007110","name":"Schering Plough","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soria Melguizo SA"},{"name":"the European Union"},{"name":"the ALBAN program"},{"name":"the Spanish Agency for International Cooperation"},{"name":"the Spanish Ministry of Culture and Education"},{"name":"The Spanish Health Research Fund"},{"name":"The Instituto de Salud Carlos III"},{"name":"The Ramon Areces Foundation"},{"name":"The Mutua Madrile\u00f1a Foundation"},{"name":"Research Projects from the Spanish Ministry of Science and Innovation","award":["SAF2008-04143"],"award-info":[{"award-number":["SAF2008-04143"]}]},{"name":"ERA-NET Pathogenomics","award":["BFU2008-04709-E\/BMC"],"award-info":[{"award-number":["BFU2008-04709-E\/BMC"]}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.riam.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T05:18:05Z","timestamp":1347686285000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Emilia","family":"Mellado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"De La Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buenaventura","family":"Buend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Rodriguez-Tudela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2012.09.002_bib0045","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"de Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2012.09.002_bib0040","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.01543-08","article-title":"Analysis of the activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and moulds","volume":"53","author":"Cuenca-Estrella","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.00942-07","article-title":"Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification","volume":"52","author":"Alcazar-Fuoli","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/JCM.01685-08","article-title":"Sequence-based identification of Aspergillus, Fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?","volume":"47","author":"Balajee","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0140","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2012.09.002_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","article-title":"Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0065","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.47.10.3085-3088.2003","article-title":"In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp.","volume":"47","author":"Gomez-Lopez","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0130","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0125","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/AAC.00933-07","article-title":"Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?","volume":"51","author":"Rodriguez-Tudela","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/13693786.2010.512926","article-title":"Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiae","volume":"49","author":"Alcazar-Fuoli","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.riam.2012.09.002_bib0055","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","article-title":"A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Diaz-Guerra","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0100","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/JCM.39.7.2431-2438.2001","article-title":"Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species","volume":"39","author":"Mellado","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0105","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0110","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/EC.00164-07","article-title":"Characterization of a novel gene for strain typing reveals substructuring of Aspergillus fumigatus across North America","volume":"6","author":"Balajee","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.riam.2012.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/JCM.00124-09","article-title":"Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus","volume":"47","author":"Hurst","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mimet.2009.03.004","article-title":"Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature","volume":"77","author":"Klaassen","year":"2009","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.riam.2012.09.002_bib0060","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.01358-10","article-title":"Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole","volume":"55","author":"Escribano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13693780902717018","article-title":"Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma","volume":"48","author":"Bellete","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.riam.2012.09.002_bib0050","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2012.09.002_bib0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-0691.2009.02911.x","article-title":"Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis","volume":"16","author":"Howard","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2012.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2012.09.002_bib0030","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.49.3.1232-1235.2005","article-title":"Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus","volume":"49","author":"Cuenca-Estrella","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0135","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.riam.2012.09.002_bib0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2012.09.002_bib0070","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/AEM.66.8.3421-3426.2000","article-title":"Tandem repeat of a transcriptional enhancer upstream of the sterol 14alpha-demethylase gene (CYP51) in Penicillium digitatum","volume":"66","author":"Hamamoto","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0095","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1128\/AEM.72.4.2581-2585.2006","article-title":"Overexpression of the 14alpha-demethylase target gene (CYP51) mediates fungicide resistance in Blumeriella jaapii","volume":"72","author":"Ma","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0090","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2012.09.002_bib0115","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance","volume":"49","author":"Mortensen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2012.09.002_bib0120","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140612000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140612000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:05:48Z","timestamp":1761105948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140612000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1130140612000873"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2012.09.002","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Revista Iberoamericana de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}